Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology Alessandro Di CerboBeniamino PalmieriTommaso Iannitti Review – Cancer Research Open access 11 May 2014 Pages: 1807 - 1814
Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity Yuli LiGuobo ShenYuquan Wei Original Article – Cancer Research 14 June 2014 Pages: 1815 - 1823
Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke Matjaz VogelsangJuliano D. PaccezM. Iqbal Parker Original Article – Cancer Research 17 June 2014 Pages: 1825 - 1833
Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression Feng HuangMei WangWenrong Xu Original Article – Cancer Research 18 June 2014 Pages: 1835 - 1848
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer Kirill LitovkinSteven JoniauMathieu Bollen Original Article - Cancer Research 18 June 2014 Pages: 1849 - 1861
The BRAF mutation is associated with the prognosis in colorectal cancer Tae Sung AhnDongjun JeongMoo-Jun Baek Original Article – Cancer Research 19 June 2014 Pages: 1863 - 1871
Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events Carolin BockChristina KuhnUdo Jeschke Original Article – Cancer Research 25 June 2014 Pages: 1873 - 1881
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO Anle ZhangYuanhong ZhengJianhui Tian Original Article – Cancer Research 01 July 2014 Pages: 1883 - 1890
LASP-1 promotes tumor proliferation and metastasis and is an independent unfavorable prognostic factor in gastric cancer Jie ZhengShuna YuShijun Lu Original Article – Cancer Research 03 July 2014 Pages: 1891 - 1899
Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis Huan WangJing HuangXiaoli Zhu Review – Clinical Oncology Open access 08 June 2014 Pages: 1901 - 1909
Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis Huan WangJing HuangXiaoli Zhu Erratum 19 September 2014 Pages: 1911 - 1911
Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients Kai ZhangTienian ZhuRuijing Zhao Original Article – Clinical Oncology 08 June 2014 Pages: 1913 - 1926
Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: Superior progression-free survival is restricted to patients with measurable tumors and objective tumor response—a retrospective study Yuan-Hao YangJen-Kou LinHao-Wei Teng Original Article – Clinical Oncology 17 June 2014 Pages: 1927 - 1936
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy Marta ScorsettiPiera NavarriaLuca Cozzi Original Article – Clinical Oncology 17 June 2014 Pages: 1937 - 1945
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma Wolfram PönischBruno HolzvogtDietger Niederwieser Original Article – Clinical Oncology 19 June 2014 Pages: 1947 - 1956
A phase II study of radiofrequency ablation therapy for thoracic malignancies with evaluation by FDG-PET Mitsunori HiguchiHiroshi HonjoMitsukazu Gotoh Original Article – Clinical Oncology 21 June 2014 Pages: 1957 - 1963
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase Michael LausekerBenjamin HanfsteinMartin C. Müller Original Article – Clinical Oncology 22 June 2014 Pages: 1965 - 1969
Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD Angela MensenIl-Kang NaBernd Gruhn Original Article – Clinical Oncology 25 June 2014 Pages: 1971 - 1980
Allogeneic stem cell transplantation in patients above 55: suggestion for a further stratification of the HCT-CI Christian SpäthChristoph BusemannWilliam H. Krüger Original Article – Clinical Oncology 26 June 2014 Pages: 1981 - 1988